Article info

Effect of IBD medications on COVID-19 outcomes: results from an international registry
Free

Authors

  1. Correspondence to Dr Ryan C Ungaro, The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; ryan.ungaro{at}mssm.edu
View Full Text

Citation

Ungaro RC, Brenner EJ, Gearry RB, et al
Effect of IBD medications on COVID-19 outcomes: results from an international registry

Publication history

  • Received July 15, 2020
  • Revised September 28, 2020
  • Accepted September 29, 2020
  • First published October 20, 2020.
Online issue publication 
March 05, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.